Additional subgroup analyses with UPCR as a continuous variable, analyzed using analysis of covariance and calculated using CKD-EPI equations based on creatinine ± cystatin C further confirmed these findings across patient subgroups with different UPCR profiles (Figure 2b and c). This evidence concerns the gene CST3 and chronic kidney disease.